ARS Pharmaceuticals, Inc. (SPRY) — Shares Outstanding
| Fiscal Year | Shares Outstanding | Change YoY |
|---|---|---|
| 2025 | 99.29M | +1.4% |
| 2024 | 97.95M | +1.6% |
| 2023 | 96.41M | +2.6% |
| 2022 | 93.94M | +209.3% |
| 2021 | 30.37M | -12.5% |
| 2020 | 34.70M | — |
| Fiscal Year | Shares Outstanding | Change YoY |
|---|---|---|
| 2025 | 99.29M | +1.4% |
| 2024 | 97.95M | +1.6% |
| 2023 | 96.41M | +2.6% |
| 2022 | 93.94M | +209.3% |
| 2021 | 30.37M | -12.5% |
| 2020 | 34.70M | — |